Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: Safety, pharmacokinetics and ammonia controlBrendan Lee, Klara Dickinson, Joseph Mauney et al.|Molecular Genetics and Metabolism|2010Cited by 90
Ammonia control in children with urea cycle disorders (UCDs); Phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrateUta Lichter‐Konecki, William J. Rhead, George A. Díaz et al.|Molecular Genetics and Metabolism|2011Cited by 74
Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxisManjula Gunawardana, Marc M. Baum, Mariana Remedios-Chan et al.|Scientific Reports|2022Cited by 19
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure ProphylaxisManjula Gunawardana, Marc M. Baum, Mariana Remedios-Chan et al.|Pharmaceutical Research|2022Cited by 6